Abstract
BackgroundOsteoarthritis (OA) may comprise multiple phenotypes, one of which is inflammation-driven OA. Consequently, a selected subpopulation of OA patients may benefit from optimally targeted anti-inflammatory treatment. Interleukin-1 (IL-1) is a...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have